The Facts About Medicare Spending
(By Kaiser Family Foundation published April 26, 2022) Medicare provides health insurance coverage for 65 million people, nearly 20% of
Read More
Part D/Prescription Drugs
Experts fear U.S. may default to annual Covid boosters without sufficient data
(By Helen Branswell for STAT) A number of vaccine experts are concerned the United States may be sleepwalking into a
Read MoreImplementing Certain Provisions of the Consolidated Appropriations Act, 2021 and other Revisions to Medicare Enrollment and Eligibility Rules (CMS-4199-P)
(Source – cms.gov/newsroom) On April 22, 2022 the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule to
Read MoreIs My Drug Copay Coupon a Form of Charity — Or a Bribe?
(By Elisabeth Rosenthal for Kaiser Health News) Before my insurer had even preapproved coverage of the new injectable medicine my
Read MoreHelp with Medicare Premium and Cost-Sharing Assistance Varies by State
(By Meredith Freed, Juliette Cubanski, Anthony Damico, and Tricia Neuman for Kaiser Family Foundation Published: Apr 20, 2022) While Medicare
Read MoreMedicare finalizes its restrictions on new Alzheimer’s drug, despite pressure from drugmakers
(By Rachel Cohrs for STAT) WASHINGTON — Medicare on Thursday finalized its plan to restrict coverage for the controversial, pricey
Read MoreHouse passes bill to cap insulin prices
(By Barbara Sprunt for NPR) The House of Representatives voted Thursday to approve legislation that would limit cost-sharing for insulin
Read MoreKFF Health Tracking Poll – March 2022: Economic Concerns and Health Policy, The ACA, and Views of Long-term Care Facilities
(By Ashley Kirzinger, Audrey Kearney, Mayesha Quasem , Mellisha Stokes , Liz Hamel, and Mollyann Brodie for Kaiser Family Foundation
Read MoreWith pharma still struggling in Alzheimer’s, health tech companies want a swing
(By Katie Palmer for STAT) In the wake of the first Alzheimer’s drug approval in nearly two decades, pharmaceutical companies
Read MoreDo I really need another booster? The answer depends on age, risk and timing
(By Maria Godoy, Allison Aubrey and Jane Greenhalgh for NPR) The Biden administration has given the go-ahead for another COVID
Read More